SCOPUS 정보 검색 플랫폼

Hospital Practice

Volumn 32, Issue 3, 1997, Pages 63-77

Advances in the treatment of Paget's bone disease

(1) Weinstein, Robert S a,b,c

a UNIVERSITY OF ARKANSAS (United States)

b Bone Histomorphometry Laboratory (United States)

c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; AMINOBISPHOSPHONATE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; COLLAGEN TYPE 1; ETIDRONIC ACID; HYDROXYAPATITE; PAMIDRONIC ACID; UNCLASSIFIED DRUG;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANALGESIA; BONE REMODELING; CASE REPORT; CLINICAL FEATURE; ESOPHAGITIS; FEMALE; FEVER; HUMAN; LYMPHOCYTOPENIA; MALE; MYALGIA; OSTEOCLAST; OSTEOLYSIS; OSTEOSARCOMA; PAGET BONE DISEASE; RADIOGRAPHY; REMISSION; REVIEW; UVEITIS;

EID: 0030971181 PISSN: 87502836 EISSN: None Source Type: Journal
DOI: 10.1080/21548331.1997.11443443 Document Type: Review

Times cited : (5)

References (9)

1
- 0018848806
- Bisphosphonates and Paget's disease
- Bijvoet OL, Reitsma PH, Frijlink WB: Bisphosphonates and Paget's disease (letter). Lancet 1:1416, 1980
- (1980) Lancet , vol.1 , pp. 1416
- Bijvoet, O.L.¹ Reitsma, P.H.² Frijlink, W.B.³

2
- 0030052388
- High-dose pamidronate in the management of resistant Paget's disease
- Cundy T, Wattie D, King AR: High-dose pamidronate in the management of resistant Paget's disease. Calcif Tissue Int 58:6, 1996
- (1996) Calcif Tissue Int , vol.58 , pp. 6
- Cundy, T.¹ Wattie, D.² King, A.R.³

3
- 0026676875
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine
- Hanson DA et al: A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Min Res 7:1251, 1992
- (1992) J Bone Min Res , vol.7 , pp. 1251
- Hanson, D.A.¹

4
- 0003588836
- Martin Dunitz, London
- Kanis JA: Pathophysiology and Treatment of Paget's Disease of Bone. Martin Dunitz, London, 1991
- (1991) Pathophysiology and Treatment of Paget's Disease of Bone
- Kanis, J.A.¹

5
- 0029821370
- Prediction of the outcome of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption
- Papapoulos SE, Frölich M: Prediction of the outcome of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption. J Clin Endocrinol Metab 81:3993, 1996
- (1996) J Clin Endocrinol Metab , vol.81 , pp. 3993
- Papapoulos, S.E.¹ Frölich, M.²

6
- 10544223736
- Biochemical and radiographic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial
- Reid IR et al: Biochemical and radiographic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial. Am J Med 101:341, 1996
- (1996) Am J Med , vol.101 , pp. 341
- Reid, I.R.¹

7
- 9044220965
- Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone
- Siris E et al: Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 81:961, 1996
- (1996) J Clin Endocrinol Metab , vol.81 , pp. 961
- Siris, E.¹

8
- 0025875602
- Familial aggregation of Paget's disease of bone
- Siris E et al: Familial aggregation of Paget's disease of bone. J Bone Miner Res 6:495, 1991
- (1991) J Bone Miner Res , vol.6 , pp. 495
- Siris, E.¹

9
- 0029155595
- Pamidronate treatment of the neurological sequelae of pagetic spinal stenosis
- Wallace E, Wong J, Reid IR: Pamidronate treatment of the neurological sequelae of pagetic spinal stenosis. Arch Intern Med 155:1813, 1995
- (1995) Arch Intern Med , vol.155 , pp. 1813
- Wallace, E.¹ Wong, J.² Reid, I.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.